These immune cells, along with type 2 mediators and cytokines (such as IL-4, IL-5, and IL-13), have been identified as contributing factors in the development of type 2 associated pathologies including CRSwNP and eosinophilic asthma (8, 15, 16). Here, IL13 is linked to chronic rhinosinusitis with nasal polyps.